scholarly journals Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study

2003 ◽  
Vol 123 (5) ◽  
pp. 810-818 ◽  
Author(s):  
Gunnar Juliusson ◽  
Martin Höglund ◽  
Karin Karlsson ◽  
Christina Löfgren ◽  
Lars Möllgård ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Cytosine Arabinoside ◽  
Phase Ii Study ◽  
Population Based ◽  
Acute Myeloid ◽  
Intermediate Dose

scholarly journals A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

2020 ◽  
Vol 190 (3) ◽  
Author(s):  
Walter Fiedler ◽  
Joerg Chromik ◽  
Stefanie Amberg ◽  
Maxim Kebenko ◽  
Felicitas Thol ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Acute Myeloid

Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II study

2008 ◽  
Vol 87 (11) ◽  
pp. 881-885 ◽  
Author(s):  
Christophe Ravoet ◽  
Philippe Mineur ◽  
Valérie Robin ◽  
Louisette Debusscher ◽  
André Bosly ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myelodysplastic Syndrome ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Farnesyl Transferase ◽  
Farnesyl Transferase Inhibitor ◽  
Acute Myeloid

scholarly journals Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS

2015 ◽  
Vol 172 (2) ◽  
pp. 238-245 ◽  
Author(s):  
Raya Mawad ◽  
Pamela S. Becker ◽  
Paul Hendrie ◽  
Bart Scott ◽  
Brent L. Wood ◽  
...  
Keyword(s):  
High Risk ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Older Patients ◽  
Phase Ii Study ◽  
Newly Diagnosed ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document